Dr. William J Wash, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 545 S York Rd, Bensenville, IL 60106 Phone: 630-766-0115 |
Dr. David A. Wold, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 535 S York Rd, Suite B, Bensenville, IL 60106 Phone: 630-766-6918 |
Dr. Karl Alan Wash, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 545 S York Rd, Bensenville, IL 60106 Phone: 630-766-0115 Fax: 630-766-1164 |
Dr. Shivam S Patel, D.D.S Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 545 S York Rd Ste 200, Bensenville, IL 60106 Phone: 630-766-0115 Fax: 630-766-1164 |
Anna Wos-kolodziejczyk, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 1332 W Irving Park Rd, Bensenville, IL 60106 Phone: 630-521-8889 Fax: 630-521-8892 |
Dr. Mark Leon Stasiulis, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 17 Lincoln St, Bensenville, IL 60106 Phone: 630-860-9080 Fax: 630-860-9086 |
Dr. Thirunindravur L. Ramadorai, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1145 S York Rd, Bensenville, IL 60106 Phone: 630-694-4937 Fax: 630-694-9953 |
Dr. Diana Dziuba-wielga, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 18 N York Rd, Bensenville, IL 60106 Phone: 630-797-8644 Fax: 630-616-8100 |
Dr. Lance Knight Skinkys, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 280 S Addison St, Bensenville, IL 60106 Phone: 630-544-9637 |
Alma Pienkowski, D.D.S Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1101 W Irving Park Rd, Suite 303, Bensenville, IL 60106 Phone: 630-860-2058 Fax: 630-860-2011 |
Peymaun Afshar Mozaffari, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 229 W Grand Ave Ste W, Bensenville, IL 60106 Phone: 630-574-9600 |
News Archive
A new review article in the June issue of Focal Points, a monthly publication of the American Academy of Ophthalmology, calls keratoprosthesis a viable alternative to standard corneal transplantation to help people suffering from corneal blindness.
Hemispherx Biopharma, Inc., announced the publication of a peer-reviewed article providing new data on Ampligen [rintatolimod; poly(I)·poly(C12,U)], an experimental therapeutic in Phase III clinical testing, in the current issue of The Journal of Applied Research.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, reported dosing of the first patient in a Phase 3 study for ARX-01, the Sufentanil NanoTab PCA System, its novel sublingual patient-controlled analgesia system.
A patient registry is proving invaluable in cataloging the clinical features, symptoms, severity, and outcomes of fibromuscular dysplasia (FMD), a non-inflammatory vascular disease that can cause narrowing of arteries in the carotid (neck) and renal (kidney) arteries, which can result in headache, strokes, and aneurysms.
Aeterna Zentaris Inc. today announced that the U.S. Food and Drug Administration has accepted for filing the Company's New Drug Application for its ghrelin agonist, macimorelin acetate, in Adult Growth Hormone Deficiency. The acceptance for filing of the NDA indicates the FDA has determined that the application is sufficiently complete to permit a substantive review.
› Verified 1 days ago